A New, AI-Augmented Horizon for Safety and Pharmacovigilance: Expert Predictions For 2026

Prepare your drug safety and pharmacovigilance processes for success and compliance in the year ahead with IQVIA’s 2026 Safety and Regulatory Compliance trends and predictions white paper. This overarching discussion details the major shifts we saw across pharmacovigilance, medical information, and regulatory intelligence in 2025 and how these processes are poised to evolve with AI integration in the year ahead. Explore how AI advancements are increasing efficiency in workflows, enabling more robust target product profiles, and leading experts to expand their technology skillsets.

Download now to explore key insights from industry experts on how to stay ahead of the AI curve.

Drug Safety and Pharmacovigilance

Harness the power of automation to execute streamlined end-to-end safety solutions while reducing costs.

Regulatory Compliance

Automate and standardize your regulatory management, from correspondence and commitments to registration and tracking.

Global Medical Information Services Enhanced by AI/NLP

In an increasingly self-serve, digital-first world, compliantly boost speed, accuracy, flexibility and coverage with AI-powered IQVIA Medical Information services

Lifecycle Safety

Harness the power of global human expertise combined with automation, artificial intelligence (AI) and machine learning (ML) to design, build and execute end-to-end safety solutions.

Local Affiliate Product Services

End-to-end safety-focused local Qualified Person for Pharmacovigilance (QPPV) services and latest PV/MI technologies, ensure global consistency at a local country level and compliance with all local safety requirements. Expand your global pharmacovigilance, Medical Information, and safety capabilities with confidence - and without additional capital investment.

To download files, please accept Functional Cookies. These cookies provide enhanced functionality for a better user experience.

Related solutions